Shilpa Medicare appoints Dr Vellaian Karuppiah as COO – Formulations

Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence

Boston Scientific surges into 2026 with double-digit sales growth & record quarterly profit jump

Growth was broad-based across segments

IMCD appoints Angelique Kruif as Global People Director

Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations

Medix Biochemica elevates Petra Furu to CEO role

With a PhD in Biochemistry and an executive MBA, she brings nearly two decades of experience in the in vitro diagnostics (IVD) sector

Medtronic launches adaptive deep brain stimulation system for Parkinson’s in India

The system is powered by BrainSense technology, which has received approval from USFDA

ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer

Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations

ECI taps industry veteran Khalid Raja to drive strategic growth

Move comes amid rising regulatory pressures

Eli Lilly to acquire Kelonia Therapeutics in up to $7 billion deal to advance cancer treatment

Zyax Chem takes 26% stake in Gaymed Labs

Targets high-growth eye care expansion push